ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Figure 1Loading Img

Palmitoylation of the Human Bradykinin B2 Receptor Influences Ligand Efficacy

View Author Information
INSERM Unité 367, 17 rue du Fer à Moulin, 75005 Paris, France, Ludwig Institute for Cancer Research, Post Office Box 595, S-75124 Uppsala, Sweden, and Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg University at Mainz, Duesbergweg 6, D-55099 Mainz, Germany
Cite this: Biochemistry 2001, 40, 51, 15743–15751
Publication Date (Web):November 30, 2001
Copyright © 2001 American Chemical Society

    Article Views





    Other access options


    To investigate the palmitoylation of the human bradykinin B2 receptor, we have mutated individually or simultaneously into glycine two potential acylation sites (cysteines 324 and 329) located in the carboxyl terminus of the receptor and evaluated the effects of these mutations by transfection in COS-7, CHO-K1, and HEK 293T. The wild-type receptor and the single mutants, but not the double mutant, incorporated [3H]palmitate, indicating that the receptor carboxyl tail can be palmitoylated at both sites. The mutants did not differ from the wild-type receptor for the kinetics of [3H]bradykinin binding, the basal and bradykinin-stimulated coupling to phospholipases C and A2, and agonist-induced phosphorylation. The nonpalmitoylated receptor had a 30% reduced capacity to internalize [3H]bradykinin. This indicates that palmitoylation does not influence the basal activity of the receptor and its agonist-driven activation. However, the mutants triggered phospholipid metabolism and MAP kinase activation in response to B2 receptor antagonists. Pseudopeptide and nonpeptide compounds that behaved as antagonists on the wild-type receptor became agonists on the nonpalmitoylated receptor and produced phospholipases C and A2 responses of 25−50% as compared to that of bradykinin. These results suggest that palmitoylation is required for the stabilization of the receptor−ligand complex in an uncoupled conformation.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

     This work was supported by INSERM and by the Bristol−Myers−Squibb Institute for Medical Research (Princeton, NJ). A.P. was supported by fellowships from the Ministère de la Recherche, the Fondation de la Recherche Médicale, and the Société de Secours des Amis des Sciences. A.B. has received a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft, and I.D. is a research fellow of the Boehringer Ingelheim Fonds.

     INSERM Unité 367.


     Ludwig Institute for Cancer Research.

     Present address:  Institute for Pharmacology, University of Heidelberg, D-69120 Heidelberg, Germany.

     Institute of Physiological Chemistry and Pathobiochemistry. Present address:  Institute for Biochemistry II, University of Frankfurt Medical School, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany.


     Corresponding author. E-mail:  [email protected].

    Cited By

    This article is cited by 24 publications.

    1. Hong Jiang, Xiaoyu Zhang, Xiao Chen, Pornpun Aramsangtienchai, Zhen Tong, and Hening Lin . Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies. Chemical Reviews 2018, 118 (3) , 919-988.
    2. Stéphanie Michineau,, François Alhenc-Gelas, and, Rabary M. Rajerison. Human Bradykinin B2 Receptor Sialylation and N-Glycosylation Participate with Disulfide Bonding in Surface Receptor Dimerization. Biochemistry 2006, 45 (8) , 2699-2707.
    3. Hongyu Yang, Qingxia Lin, Nengzhou Chen, Zhousong Luo, Chunyan Zheng, Jing Li, Fuli Zheng, Zhenkun Guo, Ping Cai, Siying Wu, Yuan-Liang Wang, Huangyuan Li. LncRNA NR_030777 Alleviates Paraquat-Induced Neurotoxicity by Regulating Zfp326 and Cpne5. Toxicological Sciences 2020, 178 (1) , 173-188.
    4. François Marceau, Marie-Thérèse Bawolak, Jean-Philippe Fortin, Guillaume Morissette, Caroline Roy, Hélène Bachelard, Lajos Gera, Xavier Charest-Morin. Bifunctional ligands of the bradykinin B 2 and B 1 receptors: An exercise in peptide hormone plasticity. Peptides 2018, 105 , 37-50.
    5. Amaly Nokkari, Hadi Abou-El-Hassan, Yehia Mechref, Stefania Mondello, Mark S. Kindy, Ayad A. Jaffa, Firas Kobeissy. Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms. Progress in Neurobiology 2018, 165-167 , 26-50.
    6. Sergio Oddi, Antonio Totaro, Lucia Scipioni, Beatrice Dufrusine, Tomasz Maciej Stepniewski, Jana Selent, Mauro Maccarrone, Enrico Dainese. Role of palmitoylation of cysteine 415 in functional coupling CB 1 receptor to Gα i2 protein. Biotechnology and Applied Biochemistry 2018, 65 (1) , 16-20.
    7. Isabel Canto, JoAnn Trejo. Palmitoylation of Protease-activated Receptor-1 Regulates Adaptor Protein Complex-2 and -3 Interaction with Tyrosine-based Motifs and Endocytic Sorting. Journal of Biological Chemistry 2013, 288 (22) , 15900-15912.
    8. Christiane Albert-Weißenberger, Anna-Leena Sirén, Christoph Kleinschnitz. Ischemic stroke and traumatic brain injury: The role of the kallikrein–kinin system. Progress in Neurobiology 2013, 101-102 , 65-82.
    9. L. M. Fredrik Leeb-Lundberg. 3 Kinin receptor signaling and regulation. 2011, 33-50.
    10. Paola Searovic, Marcelo Alonso, Carolina Oses, Karla Pereira‐Flores, Victoria Velarde, Claudia G. Saez. Effect of tamoxifen and retinoic acid on bradykinin induced proliferation in MCF‐7 cells. Journal of Cellular Biochemistry 2009, 106 (3) , 473-481.
    11. Artur Gieldon, Jakob J. Lopez, Clemens Glaubitz, Harald Schwalbe. Theoretical Study of the Human Bradykinin–Bradykinin B2 Receptor Complex. ChemBioChem 2008, 9 (15) , 2487-2497.
    12. Joëlle Gardes, Stéphanie Michineau, Anne Pizard, François Alhenc-Gelas, Rabary M. Rajerison. Aspirin inhibits human bradykinin B2 receptor ligand binding function. Biochemical Pharmacology 2008, 75 (9) , 1807-1816.
    13. Ankita Roy, Arun Kumar Shukla, Winfried Haase, Hartmut Michel. Employing Rhodobacter sphaeroides to functionally express and purify human G protein-coupled receptors. bchm 2008, 389 (1) , 69-78.
    14. Domenico Regoli, Francois Marceau. B-2 Bradykinin Receptor. 2007, 1-14.
    15. Jiri Novotny, Dana Durchankova, Richard J. Ward, Juan J. Carrillo, Petr Svoboda, Graeme Milligan. Functional interactions between the α1b-adrenoceptor and Gα11 are compromised by de-palmitoylation of the G protein but not of the receptor. Cellular Signalling 2006, 18 (8) , 1244-1251.
    16. Antonio Henrique B. Martins, Rodrigo R. Resende, Paromita Majumder, Marcella Faria, Dulce E. Casarini, Attila Tárnok, Walter Colli, João Bosco Pesquero, Henning Ulrich. Neuronal Differentiation of P19 Embryonal Carcinoma Cells Modulates Kinin B2 Receptor Gene Expression and Function. Journal of Biological Chemistry 2005, 280 (20) , 19576-19586.
    17. L. M. Fredrik Leeb-Lundberg, Francois Marceau, Werner Müller-Esterl, Douglas J. Pettibone, Bruce L. Zuraw. International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences. Pharmacological Reviews 2005, 57 (1) , 27-77.
    18. Elaine BARCLAY, Mark O'REILLY, Graeme MILLIGAN. Activation of an α2A-adrenoceptor–Gαo1 fusion protein dynamically regulates the palmitoylation status of the G protein but not of the receptor. Biochemical Journal 2005, 385 (1) , 197-206.
    19. S. Michineau, L. Muller, A. Pizard, F. Alhenc-Gélas, R. M. Rajerison. N-linked glycosylation of the human bradykinin B2 receptor is required for optimal cell-surface expression and coupling. Biological Chemistry 2004, 385 (1)
    20. Pascale G. Charest, Michel Bouvier. Palmitoylation of the V2 Vasopressin Receptor Carboxyl Tail Enhances β-Arrestin Recruitment Leading to Efficient Receptor Endocytosis and ERK1/2 Activation. Journal of Biological Chemistry 2003, 278 (42) , 41541-41551.
    21. Alexander Faussner, Alexandra Bauer, Irina Kalatskaya, Marianne Jochum, Hans Fritz. Expression levels strongly affect ligand-induced sequestration of B 2 bradykinin receptors in transfected cells. American Journal of Physiology-Heart and Circulatory Physiology 2003, 284 (6) , H1892-H1898.
    22. Timothy M. Palmer, Gail Ferguson, Kenneth R. Watterson. Dissecting the regulatory mechanisms controlling inhibitory adenosine receptor signaling. Drug Development Research 2003, 58 (4) , 302-314.
    23. A. Blaukat. Structure and signalling pathways of kinin receptors. Andrologia 2003, 35 (1) , 17-23.
    24. Dong Soo Kang, L. M. Fredrik Leeb-Lundberg. Negative and Positive Regulatory Epitopes in the C-Terminal Domains of the Human B1 and B2 Bradykinin Receptor Subtypes Determine Receptor Coupling Efficacy to G 9/11 -Mediated Phospholipase Cβ Activity. Molecular Pharmacology 2002, 62 (2) , 281-288.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect